This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zealand Pharma A/S
Drug Names(s): ZP-4207, ZP-GA-1, ZP 4207, Dasiglucagon
Description: ZP4207 is a novel glucagon analogue which has shown a strong stability profile to support its potential use as a “ready-to-use” rescue pen for the treatment of severe hypoglycemia.
Additional information available to subscribers only: